104253-44-3

Basic information

• Product Name: 2-CHLORO-4-HYDROXY-BENZOIC ACID METHYL ESTER
• Synonyms: METHYL 2-CHLORO-4-HYDROXYBENZOATE;2-CHLORO-4-HYDROXY-BENZOIC ACID METHYL ESTER;RARECHEM AL BF 0717;2-Chloro-4-hydroxy-benzoic acid methyl ester≥ 99% (GC)
• CAS NO: 104253-44-3
• Molecular Formula: C₈H₇ClO₃
• Molecular Weight: 186.59
• Product Categories: Aromatic Esters;pharmacetical
• Mol File: 104253-44-3.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 298.3 °C at 760 mmHg
• Flash Point: 134.215 °C
• Appearance: /
• Density: 1.355 g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 7.39±0.18(Predicted)
• CAS DataBase Reference: 2-CHLORO-4-HYDROXY-BENZOIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-4-HYDROXY-BENZOIC ACID METHYL ESTER(104253-44-3)
• EPA Substance Registry System: 2-CHLORO-4-HYDROXY-BENZOIC ACID METHYL ESTER(104253-44-3)

Safety Data

• Hazardous Substances Data: 104253-44-3(Hazardous Substances Data)

Usage

Chemical Properties

Tan crystalline powder

InChI:InChI=1/C8H7ClO3/c1-12-8(11)6-3-2-5(10)4-7(6)9/h2-4,10H,1H3

Upstream product

• 3336-16-1 2-chloro-4-hydroxybenzonitrile 
• 2457-76-3 4-amino-2-chlorobenzoic acid 
• 67-56-1 methanol 
• 56363-84-9 2-chloro-4-hydroxybenzoic acid 

Downstream Products

• 1035929-60-2 methyl 2-chloro-4-(4-fluorophenoxy)benzoate 
• 933799-64-5 2-chloro-4-{[5-isopropyl-3-(2,6-dichlorophenyl)-isoxazol-4-yl]methoxy}benzoic acid 
• 1374961-91-7 methyl 4-{[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-isopropyl-isoxazol-4-yl]methoxy]benzoyl]amino}benzoate 
• 1573119-81-9 4-{[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-isopropyl-isoxazol-4-yl]methoxy]benzoyl]amino}benzoic acid 
• 1573119-83-1 methyl 2-chloro-4-[[3-(2,6-dichlorophenyl)-5-isopropyl-isoxazol-4-yl]methoxy]benzoate 
• 1609477-93-1 C₁₂H₁₄BrClO₃ 
• 1609477-48-6 C₂₆H₃₁ClO₆ 
• 1609477-47-5 C₂₄H₂₉ClO₆ 
• 1609477-46-4 C₂₇H₃₃ClO₅ 
• 1609477-45-3 C₂₅H₃₁ClO₅ 
• 1609476-94-9 2-chloro-4-(4-(4-(2-cyclopentylacetyl)-3-hydroxy-2-methylphenoxy)butoxy)benzoic acid 
• 1609476-93-8 2-chloro-4-(4-(3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy)butoxy)benzoic acid 
• 1609476-92-7 2-chloro-4-(4-(4-(2-cyclopentylacetyl)-2,3-dimethylphenoxy)butoxy)benzoic acid 
• 1609476-91-6 3-chloro-4-(4-(2,3-dimethyl-4-(3-methylbutanoyl)phenoxy)butoxy)benzoic acid 

Relevant articles and documents

INHIBITORS OF RHO/MRTF/SRF-MEDIATED GENE TRANSCRIPTION AND METHODS FOR USE OF THE SAME

Disclosed herein are inhibitors of Rho/MRTF/SRF-mediated gene transcription, and methods for their use in treating or preventing diseases such as cancer and fibrosis. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically accept

ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE

Substituted aryl and heteroaryl ether compounds of the Formula (I) and pharmaceutically acceptable salts thereof, wherein X, R 1, R 2, R 3, L, R 4, L 1, Q, and R 5 are as defined herein. These compounds and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.